Skip to main content
Clinical Trials/NCT03433300
NCT03433300CompletedNot Applicable

Do Microprocessor Knees Improve Outcomes in Early Prosthetic Rehabilitation Compared to Nonmicroprocessor Knees?

University of Washington1 site in 1 country19 target enrollmentStarted: April 13, 2018Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
19
Locations
1
Primary Endpoint
Prosthetic Limb Users Survey of Mobility

Study Overview

Brief Summary

High-quality, empirical evidence to guide prosthetic rehabilitation following amputation ensures that Service members, Veterans, and civilians who experience limb loss have the potential to receive the highest quality care, regain mobility, return to gainful employment, and reintegrate into their communities. However, evidence to inform prosthetic care during the crucial post-amputation period is extremely limited. The proposed research will address this gap in knowledge by evaluating functional and patient-centered health outcomes associated with use of two distinct prosthetic knee technologies in early rehabilitation following transfemoral amputation. This novel, comparative effectiveness research aligns with the Prosthetic Outcomes Research Award (PORA) focus area of understanding the management of patient rehabilitation strategies throughout the rehabilitation process following neuromuscular injury.

The long-term goals of this project are to optimize early rehabilitation processes and associated outcomes for Service members, Veterans, and civilians with lower limb amputation. The purpose of this study is to evaluate the potential for different prosthetic knee technologies to promote function, health, and quality of life following amputation. A pilot randomized controlled trial will be conducted to compare falls, step activity, balance confidence, mobility, health-related quality of life, and community integration of people with recent transfemoral amputation in two prosthetic knee conditions: a microprocessor knee (MPK) with control of stance phase and a non-microprocessor knee (NMPK) that is appropriate for people in early rehabilitation.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Masking Description

Investigators who will conduct performance-based assessments will be blinded to the intervention.

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •18 years of age or older, Unilateral transfemoral amputation, Between 4-16 weeks post amputation, Deemed ready for prosthetic fitting by a physician, No current or prior transfemoral prosthetic use, Able to read, write and communicate in English, Weight 125kg (275lbs) or less

Exclusion Criteria

  • •Diagnosis of health condition (i.e. advanced cardiac disease, severe or end-stage pulmonary disease or severe dementia) that prevents safe prosthesis use or community ambulation with prosthesis, Weight greater than 125kg (275lbs)

Arms & Interventions

Microprocessor Knee

Experimental

Ottobock Kenevo/Ottobock C-Leg

Intervention: Ottobock Kenevo/C-Leg (Device)

Nonmicroprocessor knee

Active Comparator

Ottobock 3R60 for K3 participants, Ottobock 3R62 for K2 participants.

Intervention: Ottobock 3R60/3R62 (Device)

Outcomes

Primary Outcomes

Prosthetic Limb Users Survey of Mobility

Time Frame: Monthly for 3 months

Self-reported prosthetic mobility

Secondary Outcomes

  • Amputee Mobility Predictor (AMPPro) Assessment Tool(Monthly for 3 months)
  • Six-minute walk test(Monthly for 3 months)
  • Fall frequency(Monthly for 3 months)
  • Daily step count(Average daily step count by month for 3 months)
  • Timed up and go(Monthly for 3 months)
  • Gait quality(Monthly for 3 months)
  • Activities-Specific Balance Confidence Scale (ABC)(Baseline and monthly for 3 months)
  • Patient Reported Outcomes Measurement Information System 29-item profile (PROMIS-29) version 1.0(Baseline and monthly for 3 months)
  • Reintegration to Normal Living Index (RNLI)(Baseline and monthly for 3 months)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Sara Morgan

Acting Assistant Professor, Department of Rehabilitation Medicine

University of Washington

Study Sites (1)

Loading locations...

Similar Trials